The new side effects which weren’t present in the original Merck’s Pharmaceutical Company label warning for Fosamax made possible litigation. Side effects which were included in the original warning label are: ulcers, esophageal perforation and other problems such as cramping and diarrhea, which can appear during taking this medicine. However, some serious side effects were left out of the prospect and they were discovered through a medical investigation conducted, which concerned people who had spontaneous femure fracture even though they applied little force to the bone at the injury time. FDA took a stand and sent a directive instruction to Merck to change label warnings in a way which mentions the relation between taking the fosamax drug and bone deterioration. This is what makes possible Fosamax Litigation.

Persons are eligible for a Fosamax litigation if they are currently experiencing side effects which are linked with taking the fosamax drug.

(Sponsored attorney advertising)